Fact-checked by Grok 2 weeks ago

Lactate

Lactate, chemically designated as 2-hydroxypropanoate or the lactate ion, is a hydroxy monocarboxylic acid anion with the molecular formula C₃H₅O₃⁻, formed by the of the carboxyl group in (C₃H₆O₃). It arises primarily as a metabolic product in cells through the reversible reaction catalyzed by (LDH), an (EC 1.1.1.27) that reduces pyruvate to lactate while oxidizing NADH to NAD⁺, enabling continued under conditions and yielding a net of 2 ATP per glucose molecule. This process predominates in tissues like during high-energy demands, erythrocytes lacking mitochondria, and certain cancer cells exhibiting the Warburg effect. Historically recognized as a waste product from anaerobic metabolism, lactate was first isolated in 1780 from sour milk, where it is produced by lactic acid bacteria such as lactobacilli through fermentation. In modern physiology, however, lactate is acknowledged as a multifunctional molecule with circulatory turnover rates approximately twice that of glucose on a molar basis, serving as a primary energy substrate for oxidative tissues like the heart, brain, and liver via the and lactate shuttle mechanisms. It acts as a buffer by equilibrating NADH/NAD⁺ ratios across cell compartments and tissues, supports gluconeogenesis in the liver, and functions as a signaling molecule via the G-protein-coupled receptor HCAR1 (also known as GPR81), influencing , , and immune cell polarization. Additionally, lactate drives posttranslational modifications such as histone lactylation, which regulates in inflammatory and hypoxic environments. Elevated lactate levels, or hyperlactatemia, occur during intense exercise to redistribute resources—sparing glucose for glucose-dependent tissues like the — and in pathological states such as , ischemia, and malignancies, where it promotes tumor growth, , and by inhibiting T-cell function and shifting macrophages toward an M2 phenotype. Normal blood lactate concentrations range from 0.5 to 2.2 mmol/L, but exceed 4 mmol/L in conditions like , serving as a prognostic for outcomes in , , and cancer. Therapeutically, targeting lactate —through LDH inhibitors like galloflavin or monocarboxylate transporter (MCT) blockers such as AZD3965—shows promise in and management by reducing tumor fueling and enhancing clearance. Genetic deficiencies, such as in the LDHA subunit, can lead to rare disorders like exertional , underscoring lactate's essential role in muscle function.

Chemistry

Molecular Structure

The lactate ion has the molecular formula C₃H₅O₃⁻ and is the deprotonated conjugate base of , systematically named 2-hydroxypropanoic acid, where the carboxyl group loses its proton to form the anion. This structure consists of a three-carbon chain, with the terminal carbon bearing the group (-⁻), the central alpha carbon attached to a hydroxyl group (-OH) and a (-CH₃), and the alpha carbon serving as a chiral center due to its four different substituents: the , hydroxyl, methyl, and hydrogen. The lactate ion exists as a pair of enantiomers arising from the stereochemistry at the chiral alpha carbon. The (S)-enantiomer, known as L-lactate, rotates plane-polarized light to the left and is the biologically predominant form, while the (R)-enantiomer, or D-lactate, rotates light to the right. These enantiomers are non-superimposable mirror images, with the L-form corresponding to the (S) absolute configuration under the Cahn-Ingold-Prelog priority rules. The group in the lactate ion is planar and stabilized by , delocalizing the negative charge across the two oxygen atoms and resulting in two equivalent C-O s with lengths of approximately 1.25 , intermediate between typical single (1.43 ) and double (1.20 ) C-O bonds. This leads to bond angles in the carboxylate moiety of about 120° for the C-C-O angles and 126° for the O-C-O angle, reflecting the sp² hybridization of the carbonyl carbon. The alpha carbon adopts a tetrahedral with bond angles near 109.5°, consistent with sp³ hybridization. A standard textual representation of the lactate structure is given by the SMILES notation CC(O)C(=O)[O-], where the non-stereospecific form is shown; for the L-enantiomer, it is CC@HC(=O)[O-].

Physical and Chemical Properties

Lactate, the anion derived from (CH₃CH(OH)COO⁻), possesses a molecular weight of 89.07 g/mol. In aqueous solutions, it appears as a colorless , reflecting its ionic nature and lack of chromophores. Lactate exhibits high solubility in water, exceeding 1000 g/L at 20°C for common salts like , due to its polar ionic structure facilitating strong interactions with molecules; however, it shows limited in nonpolar solvents such as or , where values are typically below 10 g/L. As the conjugate base of , lactate participates in acid-base governed by the parent acid's of 3.86 at 25°C, corresponding to a K_a = 1.38 \times 10^{-4}. This acidity influences its behavior in aqueous environments, where it predominantly exists in deprotonated form above 4. Infrared (IR) of lactate reveals characteristic absorption bands, including a broad O-H stretch from the hydroxyl group at approximately 3400 cm⁻¹ and (COO⁻) asymmetric/symmetric stretches around 1550–1600 cm⁻¹ and 1400 cm⁻¹, respectively, though the form shows a C=O stretch near 1725 cm⁻¹. (NMR) data for lactate in include ¹H shifts at δ 1.33 ppm (, CH₃) and δ 4.11 ppm (, CH), with ¹³C shifts at approximately δ 20.9 ppm (CH₃), δ 66.7 ppm (CH), and δ 183.4 ppm (COO⁻). Lactate demonstrates thermal stability at physiological (around 7.4), remaining intact in solution, but is prone to and when heated above 100°C in acidic conditions, forming derivatives.

Synthesis and Reactions

Lactic acid, the protonated form of lactate, can be synthesized chemically through several routes, though these methods are less common today due to economic factors favoring . One classical approach involves the cyanohydrin process starting from , where reacts with to form , followed by acid to yield a racemic mixture of D- and L-lactic acid: \ce{CH3CHO + HCN -> CH3CH(OH)CN} \ce{CH3CH(OH)CN + 2H2O + H2SO4 -> CH3CH(OH)COOH + NH4HSO4} This method, discovered in 1863 by Wislicenus, was industrially scaled by Monsanto in the mid-20th century, producing up to 40% of U.S. lactic acid consumption at its peak. Another chemical route is the low-temperature oxidation of propylene glycol (1,2-propanediol) using catalysts such as gold-based or bimetallic AgPd systems with oxygen or air as the oxidant, selectively converting the secondary hydroxyl group to form lactic acid. These abiotic syntheses typically produce racemic lactic acid and rely on petrochemical feedstocks, limiting their current viability. Fermentative production, the dominant industrial method accounting for over 90% of global output, involves bacterial conversion of glucose or other s to via homolactic , primarily by species like or . The process, rooted in 19th-century discoveries—such as Scheele's isolation of from sour milk in 1780, Fremy's demonstration of in 1839, and Pasteur's identification of microbial involvement in 1857—began industrial scaling in the late 1800s in the United States and . from is then neutralized with bases like to form lactate salts, such as : \ce{CH3CH(OH)COOH + NaOH -> CH3CH(OH)COONa + H2O} This yields optically pure L-lactate, suitable for applications requiring stereospecificity. Lactate exhibits key reactivity as a weak acid, undergoing dissociation in aqueous solution: \ce{CH3CH(OH)COOH ⇌ CH3CH(OH)COO^- + H^+} with a pKa of approximately 3.86. Salt formation extends to various cations beyond sodium, enhancing solubility and stability for industrial uses. Esterification occurs readily with alcohols under acid catalysis, forming alkyl lactates like ethyl lactate via Fischer esterification: \ce{CH3CH(OH)COOH + C2H5OH ⇌ CH3CH(OH)COOC2H5 + H2O} This reversible reaction, often coupled with water removal techniques like pervaporation to shift equilibrium, produces valuable solvents and fuels. Oxidation of lactate to pyruvate proceeds selectively under catalytic conditions, such as with lead-modified palladium on carbon in aqueous alkaline media at 90°C: \ce{CH3CH(OH)COO^- + 1/2 O2 -> CH3COCOO^- + H2O} yielding up to 60% pyruvate, a critical biochemical intermediate. Additionally, lactic acid can polymerize to form polylactic acid (PLA), a biodegradable polyester, primarily via ring-opening polymerization of lactide (the cyclic dimer) using metal catalysts like Sn(II) octoate, though direct polycondensation of lactic acid is possible for lower molecular weights: n \ce{CH3CH(OH)COOH -> [-CH(CH3)COO-]_{n} + (n-1) H2O} This process enables PLA production for biomedical and packaging applications, with high-molecular-weight variants achieved through controlled stereochemistry in the ROP route.

Biochemistry

Metabolic Production

Lactate is generated in living organisms primarily as the endpoint of anaerobic glycolysis, where pyruvate, the product of the glycolytic pathway, is reduced to L-lactate. This conversion is essential for regenerating nicotinamide adenine dinucleotide (NAD⁺) from its reduced form (NADH), allowing glycolysis to continue producing ATP in the absence of sufficient oxygen. The process occurs in the cytoplasm of cells and is a key adaptation to hypoxic conditions, preventing the accumulation of pyruvate and maintaining glycolytic flux. The enzymatic reaction is catalyzed by (LDH), an classified under EC 1.1.1.27. LDH facilitates the reversible interconversion, but under conditions, the forward reaction predominates: \ce{Pyruvate + NADH + H^+ ⇌ L-Lactate + NAD^+} LDH exists as tetrameric isozymes composed of LDHA (M) and LDHB (H) subunits, with the LDHA-dominant form (LDH5) favoring pyruvate reduction to lactate in glycolytic tissues. This reaction yields two molecules of lactate per glucose molecule metabolized, supporting rapid but limited ATP generation (net 2 ATP per glucose). Major sites of lactate production include cells during high-intensity exercise, erythrocytes lacking mitochondria and relying solely on , and the through . In , lactate accumulation initiates the , transporting the metabolite to the liver for conversion back to glucose via . Erythrocytes produce lactate continuously to meet their energy needs, with rates increasing under stimuli like insulin. Gut contribute significantly to D-lactate production, distinct from the L-form generated by eukaryotic LDH. Regulation of lactate production involves transcriptional control, notably by hypoxia-inducible factor 1 (HIF-1), which binds to the promoter region of the LDHA gene to upregulate its expression during . This enhances LDH activity and shifts toward lactate formation, as seen in the interaction between HIF-1 sites and cAMP response elements in the LDH-A promoter. Eukaryotic cells produce predominantly L-lactate via LDH, while certain gut bacteria, such as species, generate D-lactate using D-specific lactate dehydrogenases during , leading to distinct physiological implications.

Role in Cellular Energy

Lactate serves as a key oxidative fuel in multiple tissues, where it is converted back to pyruvate via the reverse reaction catalyzed by lactate dehydrogenase (LDH), enabling entry into the tricarboxylic acid (TCA) cycle and subsequent ATP generation through oxidative phosphorylation. In the heart, this process supports substantial energy demands, with lactate accounting for over 50% of the oxidative substrate utilized by cardiomyocytes during periods of increased workload. Similarly, in the liver, mitochondrial LDH facilitates lactate oxidation to maintain energy homeostasis and support gluconeogenesis precursors, while in the brain, lactate oxidation via LDH provides an efficient energy substrate, particularly when glucose uptake is limited. The intracellular lactate shuttle enhances this metabolic role by transporting cytosolically produced lactate directly to mitochondria within the same cell, where mitochondrial LDH (mLDH) oxidizes it to pyruvate in the , coupling the reaction to the via the lactate oxidation complex (LOX). This shuttle operates in energy-demanding tissues like the heart, , and neurons, bypassing cytosolic limitations and optimizing aerobic metabolism. The proposed astrocyte-neuron lactate shuttle (ANLS) hypothesizes that astrocytes glycolytically produce lactate from glucose or , which is then exported via monocarboxylate transporters (MCT1/4) and taken up by neurons through MCT2 for oxidation into pyruvate and ATP production, supporting synaptic activity and neuronal function. However, the remains debated, with recent evidence as of 2025 questioning its essential role in neuronal energy metabolism. Differential LDH isozymes—LDH5 in favoring lactate production and LDH1 in neurons favoring oxidation—drive this directional energy transfer. As a signaling molecule, lactate binds to the G-protein-coupled receptor GPR81 (also known as HCAR1), primarily expressed in , immune cells, and certain tumor tissues, activating Gαi-mediated inhibition of adenylate cyclase and reducing cyclic AMP () levels. This pathway suppresses in by decreasing hormone-sensitive activity, thereby limiting free release and promoting storage during metabolic shifts. In inflammatory contexts, GPR81 activation by lactate attenuates pro-inflammatory responses, such as reducing interleukin-1β (IL-1β) secretion and activity in macrophages, fostering an that mitigates tissue damage. Under stress conditions, significantly contributes to ATP production, supplying up to 60% of the brain's needs by serving as a readily oxidizable during heightened neuronal activity. In cancer cells, the Warburg effect—characterized by aerobic and lactate production via LDH-A—enables rapid ATP generation, with accounting for 40–75% of total ATP in proliferating tumors, while exported lactate can be shuttled to nearby cells for oxidation, further supporting the tumor microenvironment's demands.

Lactate Shuttle Hypothesis

The lactate shuttle hypothesis proposes that lactate functions as a mobile energy substrate, facilitating the transfer of reducing equivalents and carbon skeletons between producing and consuming cells or organelles, thereby integrating glycolytic and oxidative metabolism under both resting and exercising conditions. First articulated by physiologist George A. Brooks in the mid-1980s, the hypothesis emerged from tracer infusion studies in rats revealing simultaneous lactate production and utilization during , contradicting the long-held view—dating to the early —that lactate is solely an end product of accumulated as waste. Brooks' seminal work demonstrated that lactate fluxes exceed those of glucose, positioning lactate as a central hub in rather than a metabolic dead-end. At the intracellular level, the hypothesis describes lactate shuttling from the —where it forms via (LDH) during —to the mitochondria for oxidation. This process relies on the mitochondrial lactate oxidation complex (mLOC), a functional unit comprising MCT1 (a high-affinity monocarboxylate transporter), mitochondrial LDH, and , which enables lactate entry, conversion to pyruvate, and subsequent entry into the . MCT1, encoded by the SLC16A1 gene, exhibits a low for lactate (around 3-5 ) and is enriched in oxidative tissues, supporting efficient uptake. In contrast, MCT4 (SLC16A3), with a higher (22-34 ), predominates in glycolytic cells and facilitates lactate efflux to maintain cytosolic and balance. This shuttling ensures that glycolytically derived lactate contributes directly to aerobic ATP production without requiring prior pyruvate reconversion in the cytosol. Intercellularly, the shuttle enables lactate exchange between specialized cell types, driven by concentration and pH gradients across tissues. For example, during physical activity, lactate produced by glycolytic fast-twitch muscle fibers is exported via MCT4 and imported by oxidative slow-twitch fibers or cardiomyocytes through MCT1, providing fuel to the heart where it can account for up to 60% of energy needs. In the brain, astrocytes generate lactate from glucose under glutamatergic stimulation and release it via MCT4 for neuronal uptake via MCT1 or MCT2, supporting synaptic activity in the astrocyte-neuron lactate shuttle (ANLS). The MCT family, consisting of 14 isoforms with varying substrate affinities and tissue distributions, underpins these transfers; MCT1 and MCT4 form a cooperative system where MCT4 handles high-flux export from producers and MCT1 manages uptake in consumers. This dynamic redistribution optimizes energy allocation across organs, such as from skeletal muscle to the heart or brain. Recent studies as of 2025, including genetic models, affirm the shuttle's role in muscle and heart but highlight ongoing debate regarding its universality, particularly in the brain. Supporting evidence derives primarily from isotopic tracing experiments using stable (¹³C) or radioactive (¹⁴C) lactate tracers, which quantify turnover and oxidation rates in vivo. In resting humans and animals, lactate oxidation accounts for approximately 8-12% of brain energy needs and contributes to whole-body metabolism, with fluxes often comparable to glucose. During moderate exercise, lactate oxidation can contribute significantly to energy provision in oxidative tissues (e.g., up to 60% in the heart), with whole-body lactate fluxes often 1.5-3 times those of glucose, though direct oxidation rates vary by intensity and tissue (typically 20-30% of total carbohydrate oxidation). Early studies by Brooks and colleagues in the 1980s, using arterio-venous difference methods combined with tracers, showed rapid lactate clearance via oxidation in working muscles and the heart. More recent work, including multi-tracer infusions in mice, confirms lactate as the highest-turnover gluconeogenic precursor, with whole-body fluxes exceeding glucose by 1.1-fold in fed states and 2.5-fold during fasting. Reviews through the 2020s, such as Brooks (2022), synthesize these findings, affirming the shuttle's role in health and disease, though critiques highlight challenges in isolating mitochondrial lactate uptake (e.g., potential artifacts in cell fractionation) and debates over whether shuttling universally applies beyond muscle and brain tissues.

Physiology

Lactate in Exercise

During physical exercise, lactate production increases as muscle cells shift toward to meet energy demands when oxygen supply is limited. This leads to the onset of blood lactate accumulation (OBLA), typically occurring at blood concentrations around 4 mmol/L, which is closely associated with the anaerobic threshold—the point at which lactate begins to accumulate faster than it can be cleared. OBLA serves as a marker of where aerobic is supplemented by anaerobic pathways, influencing performance. Contrary to earlier beliefs, lactate itself does not directly cause muscle fatigue; instead, the accompanying buildup of hydrogen ions (H+) from glycolysis lowers pH, inducing acidosis that impairs muscle contraction and enzyme function. This acidosis is partially buffered by bicarbonate ions in the blood, which helps mitigate the drop in pH during intense efforts, though excessive H+ accumulation still contributes to perceived exertion and reduced performance. Endurance training induces adaptations that enhance lactate dynamics, including increased mitochondrial density in muscle fibers for better aerobic oxidation of lactate and upregulated expression of monocarboxylate transporters (MCTs), particularly MCT1 and MCT4, which facilitate lactate shuttling and clearance. These changes allow trained individuals to tolerate higher lactate levels and recover more efficiently, delaying OBLA and improving overall exercise capacity. Historically, was vilified in the by physiologist A.V. Hill, who proposed the concept of "lactic acid debt" or "oxygen debt," attributing post-exercise fatigue and recovery oxygen needs to accumulated . Modern understanding has shifted this view, recognizing as a valuable rather than a waste product, with the lactate shuttle hypothesis explaining its role in inter-organ transfer during and after exercise.

Blood Lactate Levels

lactate levels in healthy adults at rest typically range from 0.5 to 2.2 mmol/L, reflecting balanced production and clearance under normal physiological conditions. During intense exercise, these levels can rise substantially, peaking at up to 20 mmol/L or higher due to accelerated in . Such elevations signify a shift toward greater reliance on as an but return to baseline with recovery, illustrating lactate's role in metabolic adaptation rather than mere accumulation. Several physiological and environmental factors influence blood lactate concentrations. Advancing age is associated with a reduced , meaning higher lactate buildup occurs at lower relative exercise intensities, potentially due to diminished mitochondrial function and oxidative capacity. At high altitudes, paradoxically lowers exercise-induced lactate accumulation, attributed to enhanced aerobic efficiency and reduced glycolytic flux despite hypoxic . Hyperlactatemia is defined as blood lactate exceeding 2 mmol/L and indicates disrupted lactate homeostasis. It is categorized into type A, resulting from tissue hypoxia or hypoperfusion such as in shock or severe anemia, and type B, arising without overt oxygenation deficits, often linked to conditions like liver dysfunction, malignancies, or certain medications that impair lactate metabolism. These distinctions guide clinical interpretation, as type A reflects acute circulatory compromise while type B signals underlying metabolic derangements. In critical illnesses, blood lactate levels serve as a key prognostic marker, particularly in and . Concentrations above 4 mmol/L are strongly associated with increased mortality risk, reflecting severe hypoperfusion and multi-organ dysfunction; for example, persistent hyperlactatemia despite predicts poor outcomes in patients. Even moderate elevations, such as 2-4 mmol/L, correlate with adverse when sustained, underscoring lactate's utility in risk stratification and therapeutic monitoring.

Clearance and Homeostasis

Lactate clearance primarily occurs through hepatic gluconeogenesis via the Cori cycle, where two molecules of lactate are converted to one molecule of glucose in the liver, consuming six ATP molecules in the process. This cycle recycles lactate produced in peripheral tissues, such as skeletal muscle during anaerobic conditions, back into glucose for systemic distribution, thereby maintaining carbohydrate homeostasis. Under normal conditions, the liver accounts for approximately 60% of total lactate clearance through this mechanism. Extrahepatic tissues contribute significantly to lactate removal, with oxidation occurring in organs like the kidney and heart, accounting for up to 30% of total clearance. In the kidney, lactate generated in the proximal tubule is oxidized in the distal tubule to support local energy needs, while the heart preferentially utilizes circulating lactate as an oxidative fuel, particularly during exercise, via lactate dehydrogenase-mediated conversion to pyruvate for entry into the tricarboxylic acid cycle. These processes help buffer lactate levels, preventing excessive accumulation even as blood concentrations may rise transiently to 1-2 mmol/L during moderate activity. Hormonal factors regulate lactate dynamics to balance production and clearance. Adrenaline (epinephrine) stimulates lactate production by enhancing and Na+/K+-ATPase activity in tissues, increasing circulating levels during stress or exercise. In contrast, insulin promotes lactate clearance by modulating activity and facilitating hepatic glucose metabolism, thereby supporting from lactate. Disruptions in clearance mechanisms, such as , impair the by reducing hepatic gluconeogenic capacity, leading to lactate accumulation and elevated blood levels. This highlights the liver's central role in maintaining lactate , where failure shifts reliance to extrahepatic pathways that cannot fully compensate.

Medical and Clinical Aspects

Lactic Acidosis

Lactic acidosis is a serious defined by an arterial blood pH below 7.35 accompanied by elevated serum lactate concentrations exceeding 4 mmol/L, typically with an increased greater than 12 mEq/L. This condition arises from excessive production or impaired clearance of lactate, leading to a profound acid-base imbalance that can compromise organ function. While blood lactate levels above 2 mmol/L indicate hyperlactatemia, the specifically refers to the pH drop, distinguishing it from non-acidotic elevations. The classification of lactic acidosis, originally proposed by and in 1976, divides it into two main types based on underlying mechanisms. occurs in the presence of tissue or hypoperfusion, such as in , , severe anemia, or , where anaerobic metabolism predominates. In contrast, develops without evident and is associated with conditions like malignancies (e.g., or promoting aerobic ), liver , renal disease, or medications including metformin, biguanides, and certain antiretroviral drugs. Examples of Type B triggers also include and mitochondrial disorders, highlighting diverse non-hypoxic pathways to lactate accumulation. Clinically, lactic acidosis manifests with nonspecific symptoms that escalate with severity, including , , , , and as compensatory attempts to correct the . In advanced cases, patients may experience altered mental status, , , and multiorgan failure, often culminating in high mortality rates of 20% to 50% or more, particularly in Type A forms linked to or . Lactic acidosis was first described in the in 1920, with further insights into its etiology from accumulation reported by Clausen in 1925. guidelines have evolved in the to emphasize rapid identification and treatment of underlying causes, incorporating fluid , vasopressors for hemodynamic support, and when indicated, alongside cautious use of for severe (pH <7.1). Recent updates, such as those in the 2021 Surviving Campaign, underscore lactate-guided to improve outcomes in critical care settings.

Diagnostic Measurement

Lactate levels in blood are commonly measured through sampling from either or sites, with often serving as a practical alternative to in clinical settings. Studies indicate that venous lactate concentrations are typically higher than arterial levels by 0.18 to 1.06 mmol/L, though a strong correlation exists between the two, particularly in conditions like where peripheral venous measurements can reliably substitute for arterial ones. Point-of-care analyzers, such as the i-STAT system, enable rapid bedside assessment of lactate using small samples, providing results in approximately 2 minutes with high reliability and low bias compared to central methods. These devices demonstrate coefficients of variation below 5% for lactate measurements and show minimal mean differences (e.g., -0.0227 ± 0.4542 mmol/L) against analyzers. In contrast, laboratory-based serves as the gold standard, employing enzymatic reactions on larger samples for precise quantification, though it requires more time for processing and transport. The enzymatic underpinning most lactate measurements relies on (LDH), which catalyzes the conversion of lactate to pyruvate while reducing NAD⁺ to NADH; the reaction is quantified by monitoring the increase in at 340 nm due to NADH formation. This method ensures specificity and , with the rate of absorbance change directly proportional to lactate concentration. Non-invasive alternatives, such as (NIRS), estimate muscle lactate levels by detecting changes in tissue oxygenation and metabolic byproducts without blood sampling, offering potential for continuous monitoring during exercise or critical care. These devices achieve standard errors as low as 0.29 mmol/L when calibrated against enzymatic assays, though limitations include variability from pigmentation, motion artifacts, and indirect inference rather than direct measurement, reducing overall accuracy in dynamic clinical environments. According to the Surviving Sepsis Campaign guidelines (2021), serial blood lactate measurements are recommended every 2–4 hours in adults with suspected or if the initial level exceeds 2 mmol/L, to guide efforts and assess response to .

Therapeutic Applications

Lactate plays a significant role in therapeutic interventions, particularly through its use in intravenous fluids to manage acid-base disturbances. infusion, often as part of , is employed to treat by providing a metabolizable that is converted to in the liver. This solution typically contains 28 mmol/L of lactate, along with sodium, , calcium, and chloride ions, making it suitable for volume in conditions such as or . Clinical guidelines recommend its use in scenarios requiring correction of without the direct administration of , as the lactate anion helps restore balance while supporting . As an alternative to , lactate-buffered solutions like Ringer's lactate are integrated into protocols, especially for patients, where they provide buffering capacity during hemorrhagic . Studies from the 2010s have demonstrated that these solutions can improve hemodynamic stability and potentially reduce mortality in select cases by avoiding complications associated with or CO2 production from . For instance, in control strategies, lactate-based fluids have been associated with better outcomes compared to chloride-rich alternatives, emphasizing their role in permissive management. In the management of (SBS), D-lactate accumulation can lead to , and targeting D-lactate-producing bacteria offer a therapeutic approach to prevent this complication. Synbiotic therapies, combining with prebiotics, have been proposed to modulate , reducing D-lactate overproduction and alleviating neurological symptoms in SBS patients. Emerging research also highlights lactate's potential in , where topical lactate application or lactate-producing bacteria promote , reduce , and accelerate tissue repair, with studies showing up to 30% faster healing rates in treated wounds. Despite these applications, lactate infusions carry contraindications, particularly in severe , where impaired hepatic clearance can hinder lactate metabolism to , potentially worsening . Caution is advised in such cases, with alternative fluids preferred to avoid exacerbating metabolic imbalances.

Industrial and Other Uses

Food and Beverage Production

has been employed in since ancient times, with evidence of vegetables using this process dating back to civilizations in and ancient around 2000 BCE, where and other produce were preserved through natural microbial action to extend during seasons of scarcity. This method relies on (LAB), primarily species of the genus , which convert sugars in raw materials into , lowering the and creating an acidic environment inhospitable to spoilage organisms. In modern applications, biotechnological advancements have introduced engineered strains optimized for higher efficiency, faster acid production, and improved flavor consistency in industrial settings, enhancing scalability while maintaining traditional outcomes. A primary role of lactate in food production occurs through , where species dominate the microbial community to produce from carbohydrates, typically yielding concentrations of approximately 1–2% in the final product, which exists primarily as lactate salts due to interactions with food matrix ions. In production, Lactobacillus delbrueckii subsp. bulgaricus and ferment in milk, generating about 0.9–1.2% to achieve a of 4.4–4.6, resulting in and the characteristic tangy flavor. Similarly, sauerkraut fermentation involves followed by Lactobacillus plantarum, converting sugars to yield around 1.5% , preserving the vegetable's crunch and nutritional value. , a fermented dish, undergoes a comparable process dominated by Lactobacillus sakei and species, reaching 0.4–0.8% for optimal acidity and content. Lactate also serves as a direct in the form of (E325) and (E327), recognized as acidity regulators that adjust and buffer formulations in products like baked goods, meats, and beverages to improve texture and stability. These compounds have been affirmed as (GRAS) by the U.S. under 21 CFR 184.1768 for and 21 CFR 184.1207 for , allowing their use at levels up to 4.7% in specific applications without posing health risks. Beyond regulation, lactate extends through its properties, which disrupt microbial membranes and reduce in food matrices, effectively inhibiting pathogens such as in ready-to-eat meats and . For instance, incorporation of 1.8–3% sodium or potassium lactate in or frankfurters has been shown to delay L. monocytogenes by up to 2–3 log cycles during refrigerated storage, enhancing without altering sensory qualities. This preservative action complements natural , making lactate a versatile tool in both traditional and processed food industries.

Pharmaceutical Uses

Lactic acid and its salts, such as , serve as excipients in various pharmaceutical formulations, particularly injectables, where they function as buffering agents and modifiers to maintain and . For instance, in antibiotic preparations like intravenous solution (Cipro IV), acts as a solubilizing agent to enhance drug efficacy in acidic environments. This role is critical in parenteral products, ensuring compatibility with active ingredients and preventing degradation during storage or administration. Polylactide (PLA), a derived from , is widely utilized as an active component in controlled-release systems, including biodegradable implants. PLA's and into non-toxic lactate metabolites make it suitable for sustained drug release over weeks to months, reducing the need for frequent dosing. The U.S. (FDA) has approved PLA-based formulations for medical applications since the , with examples including implants for hormone delivery and scaffolds that encapsulate therapeutics like contraceptives or chemotherapeutics. These systems degrade gradually , providing localized treatment while minimizing systemic side effects. In topical pharmaceuticals, lactate esters and salts like sodium lactate are incorporated into moisturizers to enhance skin barrier function and hydration. As a humectant, sodium lactate draws moisture into the stratum corneum, promoting ceramide production and reducing transepidermal water loss, which is particularly beneficial for conditions like xerosis. Clinical evaluations have shown that formulations containing 5% sodium lactate combined with urea improve skin barrier integrity and alleviate dryness in older adults with impaired barrier function. This application leverages lactate's natural role in epidermal physiology to support long-term skin health without irritation. Ongoing research explores lactate-based nanoparticles for targeted , focusing on their responsiveness to tumor microenvironments rich in lactate due to the Warburg effect. These nanoparticles, such as enzyme-assisted mesoporous silica variants, enable pH-sensitive drug release specifically at tumor sites, enhancing efficacy of chemotherapeutics like while sparing healthy tissues. As of 2025, preclinical and early-phase trials investigate these systems for solid tumors, including and colorectal cancers, with promising results in tumor-specific accumulation and reduced .

Environmental Role

Lactate, the ionized form of lactic acid, undergoes rapid microbial biodegradation in natural environments such as soil and water, primarily through aerobic processes mediated by bacteria including species of Pseudomonas. These microorganisms utilize lactate as a carbon and energy source, converting it to carbon dioxide and water via metabolic pathways involving lactate dehydrogenases. Under aerobic conditions, Pseudomonas aeruginosa strains have demonstrated efficient lactate utilization, supporting the degradation of lactate derived from organic waste or polymer breakdown. The half-life of lactate in aerobic soil and water is typically on the order of days, reflecting its classification as a readily biodegradable compound, with over 60% degradation often achieved within 28 days in standard tests, though actual rates vary with temperature, pH, and microbial density. In , lactate present in industry effluents—arising from processes in processing—serves as a key for , facilitating production. consortia, including methanogenic and acidogenic , break down lactate into volatile fatty acids and subsequently , yielding with contents up to 68%. For instance, pretreatment of with anaerobic sludge can reduce (COD) by over 99%, while co-digestion of lactate-rich streams enhances overall yields by up to 45% compared to non-lactate substrates. This process not only mitigates from high-organic-load effluents but also recovers energy, with typical yields around 0.33 L per gram of COD removed under optimized conditions. Lactate plays an indirect role in through eutrophication-driven processes, where nutrient enrichment promotes algal blooms and subsequent bacterial respiration or in hypoxic zones. As decomposes, shift to , increasing lactate production alongside CO2 release, which lowers and exacerbates acidification. This linkage is evident in coastal estuaries, where eutrophication-enhanced microbial activity contributes to declines of up to 0.5 units, impacting calcifying organisms and amplifying global trends. An emerging environmental concern involves the degradation of (PLA) plastics, which release lactate as microplastics fragment in and systems. Studies from the indicate that hydrolytic and microbial breakdown of PLA generates oligomers and free lactate, potentially altering local and stimulating acid-tolerant microbial communities, with implications for and carbon cycling. For example, PLA microplastics in soil can lower pH by 0.2–0.5 units over months, influencing availability and , though full mineralization to CO2 occurs slowly under ambient conditions.

References

  1. [1]
    Lactate | C3H5O3- | CID 91435 - PubChem - NIH
    Lactate is a hydroxy monocarboxylic acid anion that is the conjugate base of lactic acid, arising from deprotonation of the carboxy group.
  2. [2]
    Biochemistry, Lactate Dehydrogenase - StatPearls - NCBI Bookshelf
    Lactate dehydrogenase (LDH) is an important enzyme of the anaerobic metabolic pathway. It belongs to the class of oxidoreductases, with an enzyme commission ...
  3. [3]
    Lactate metabolism in human health and disease - PMC
    Lactate is a classical byproduct of glucose metabolism, and the main lactate production pathway depends on glycolysis (Fig. 1). The glycolysis pathway is ...Missing: definition | Show results with:definition
  4. [4]
    Lactate: the ugly duckling of energy metabolism - PMC - NIH
    Jul 20, 2020 · Lactate, perhaps the best-known metabolic waste product, was first isolated from sour milk, in which it is produced by lactobacilli.
  5. [5]
    Lactate: a multifunctional signaling molecule - PMC - NIH
    Feb 18, 2021 · Lactate is a multifunctional signaling molecule with its own receptor and plays an important role in communication between cells and tissues.
  6. [6]
    (S)-Lactate | C3H5O3- | CID 5460161 - PubChem - NIH
    (S)-lactate is an optically active form of lactate having (S)-configuration. It has a role as a Saccharomyces cerevisiae metabolite.Missing: stereochemistry | Show results with:stereochemistry
  7. [7]
    Lactic acid enantiomers; L (+, S)-and D (-, R) - ResearchGate
    L-lactic acid is the more common form and is produced by body tissues under hypoxic conditions or by bacterial fermentation mainly in the gastrointestinal tract ...
  8. [8]
    Short Carboxylic Acid-Carboxylate Hydrogen Bonds Can Have Fully ...
    Fully protonated carboxylic acids have unequal carboxylic acid bond lengths of 1.21 Å for a C=O bond and 1.30 Å for a C-OH bond, while deprotonated carboxylates ...
  9. [9]
  10. [10]
    What is the degree of angle and hybridization for lactic acid? - Echemi
    Carbon 1 (the -COOH carbon) is sp2 hybridized with a 120 degree bond angle. Carbons 2 and 3 are both sp3 hybrized with basically 109 degree bond angles.Missing: molecular structure lengths
  11. [11]
  12. [12]
    Sodium lactate | 72-17-3 - ChemicalBook
    Aug 6, 2025 · Sodium lactate Properties ; 0.7 (vs air) · 17.535 mm of Hg (@ 20°C) · 1.422-1.425 · 2-8°C · Miscible with ethanol (95%), and with water.
  13. [13]
    Transmission FT-IR Study on the Adsorption and Reactions of Lactic ...
    Sep 28, 2010 · (21) For the lactic acid and lactate, the infrared bands in the range 1045−1475 cm−1 are similar. The main differences are the υ(C═O) at 1725 cm ...
  14. [14]
    Vibrational spectra of lactic acid and lactates - Wiley Online Library
    The Raman and IR spectra of lactic acid and sodium lactate in aqueous solution and methyl lactate as a pure liquid were recorded from 3600 to 100 cm-'.
  15. [15]
    bmse000269 (R)-Lactate at BMRB
    Assigned chemical shifts. Set 1. Sample: 100mM in D2O, ref: DSS Conditions ... 6: 2D [1H,13C]-HSQC Sample: 100mM in D2O, ref: DSS Conditions: temperature ...
  16. [16]
    The Lactate and the Lactate Dehydrogenase in Inflammatory ...
    Lactate dehydrogenase (LDH) is a terminating enzyme in the metabolic pathway of anaerobic glycolysis with end product of lactate from glucose.
  17. [17]
    The Multiple Roles of Lactate in the Skeletal Muscle - PMC
    Jul 10, 2024 · The production of lactate in skeletal muscle is the result of lactic fermentation, which is activated during intense anaerobic exercise [3].
  18. [18]
    Regulation of human erythrocyte metabolism by insulin - PubMed
    We show that insulin increases the rate of glycolysis in human erythrocytes. Lactate production increased 56 and 173% in the presence of 10 and 100 nM insulin, ...
  19. [19]
    D-Lactate: Implications for Gastrointestinal Diseases - NIH
    May 26, 2023 · D-lactate is produced in very low amounts in human tissues. However, certain bacteria in the human intestine produce D-lactate.
  20. [20]
    Hypoxic regulation of lactate dehydrogenase A. Interaction between ...
    Sep 8, 1995 · Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements · Authors · Affiliation.
  21. [21]
    The role of lactate in cardiovascular diseases
    Nov 3, 2023 · Especially during exercise, lactate can provide over 50% of the energy required by cardiomyocytes [54]. During exercise, lactate production ...
  22. [22]
    Intracellular Shuttle: The Lactate Aerobic Metabolism - PMC
    The Intracellular Lactate Shuttle hypothesis states that lactate first enters in mitochondria and only then is metabolized.
  23. [23]
    Brain energy homeostasis: the evolution of the astrocyte-neuron ...
    Jan 1, 2025 · The ANLS hypothesis explains how astrocytes provide lactate to neurons for energy. This involves glutamate release, astrocyte lactate ...
  24. [24]
    Understanding lactate sensing and signalling - ScienceDirect.com
    Lactate signalling through GPR81 is responsible for insulin-driven prevention of lipolysis by inhibiting cAMP production [19]. In mice, the lactate-GPR81-p38 ...
  25. [25]
    Effects of psychosocial and physical stress on lactate and anxiety ...
    Lactate provides up to 60% of the total energy supply of the human brain ... Rise in plasma lactate concentrations with psychosocial stress: a possible sign of ...
  26. [26]
    Revisiting the Warburg Effect with Focus on Lactate - PMC
    Here, we discuss recent findings on lactate metabolism and signaling in cancer while attempting to explain why the Warburg effect is adopted by cancer cells.
  27. [27]
  28. [28]
    Tracing the lactate shuttle to the mitochondrial reticulum - PMC
    Studies using isotope tracer technologies have significantly improved understanding of how lactate, a metabolite produced as fuel during normal metabolism and ...
  29. [29]
    Lactic acid test: MedlinePlus Medical Encyclopedia
    Jun 20, 2023 · Normal results range from 4.5 to 19.8 milligrams per deciliter (mg/dL) (0.5 to 2.2 millimoles per liter [mmol/L]). Normal value ranges may vary ...
  30. [30]
    Lactate Profile | UC Davis Sports Medicine
    The concentration of blood lactate is usually 1-2 mmol/L at rest, but can rise to greater than 20 mmol/L during intense exertion. Blood lactate levels ...
  31. [31]
    Plasma lactate measurement as an example of encountered gaps ...
    Oct 24, 2018 · Lactate levels in normal subjects ranged from 0.6 to 3.1 mmol/L (median 1.1). Patient lactate levels ranged from 0.8 to 26.3 mmol/L (median 2.2) ...
  32. [32]
    Endurance exercise performance in Masters athletes: age ... - PubMed
    Jan 1, 2008 · A reduction in lactate threshold, i.e. the exercise intensity at which blood lactate concentration increases significantly above baseline, also ...<|control11|><|separator|>
  33. [33]
    Increased resting lactate levels and reduced carbohydrate intake ...
    Increased resting lactate levels and reduced carbohydrate intake cause νLa.max underestimation by reducing net lactate accumulation—A pilot study in young ...
  34. [34]
    The Lactate Paradox in Human High-Altitude Physiological ...
    During maximum aerobic exercise, high-altitude natives generate lower-than-expected amounts of lactate; the higher the altitude, the lower the postexercise ...
  35. [35]
    Time-of-day effects in maximal anaerobic performance and blood ...
    No significant circadian variation was observed for body weight, resting heart rate and blood lactate concentrations between all measured time units(p>0.05).<|control11|><|separator|>
  36. [36]
    Persistent Lactate Elevation in a Patient with Asthma Exacerbation ...
    Jan 17, 2025 · Hyperlactatemia is defined as lactate above 2 mmol/L, while levels above 4 mmol/L represent lactic acidosis. The impact of lactic acidosis ...
  37. [37]
    Lactic Acidosis - StatPearls - NCBI Bookshelf - NIH
    Apr 28, 2025 · The condition is defined by a serum lactate concentration above 4 mmol/L, often accompanied by a blood pH below 7.35 and low plasma bicarbonate ...
  38. [38]
    Retrospective evaluation of potential causes associated with ...
    Cases were defined as having mixed hyperlactatemia if they had evidence of one or more criteria or cause compatible with type A and type B hyperlactatemia.
  39. [39]
    Lactate as a Biomarker for Sepsis Prognosis? - PMC - PubMed Central
    Hyperlactatemia (most commonly ≥4 mmol/L) is a marker of sepsis-induced hypoperfusion and the threshold was incorporated into the Surviving Sepsis Campaign (SSC) ...
  40. [40]
    New clinical criteria for septic shock: serum lactate level as new ...
    Since the serum lactate level was decreased to 2 mmol/L, serum lactate level is a more sensitive marker for septic shock. Notably, serum lactate level >2 mmol/L ...
  41. [41]
    Distinct glycolytic pathway regulation in liver, tumor and skeletal ...
    The classical Cori cycle that involves shuttling of lactate and glucose ... lactate uptake into the liver for use in gluconeogenesis (6 ATP cost). In our ...
  42. [42]
    Lactate and lactate clearance in acute cardiac care patients - PMC
    Under conditions of normal lactate blood concentrations, the most important mechanism of renal lactate removal is the lactate re-uptake, which could remove up ...
  43. [43]
    Sepsis-associated hyperlactatemia - PMC - PubMed Central - NIH
    Human and animal studies have demonstrated that epinephrine increases lactate formation by an increase in the Na+/K+-ATPase activity [45,69]. Levy and ...Missing: adrenaline | Show results with:adrenaline
  44. [44]
    Lactic Acidosis: Background, Etiology, Epidemiology
    Jan 22, 2025 · Cohen and Woods divided lactic acidosis into two categories, type A and type B. Type A is lactic acidosis occurring in association with clinical ...
  45. [45]
    Review L-lactic acidosis: pathophysiology, classification, and causes
    Almost 50 years ago, Cohen and Woods proposed a classification of L-LA into type A (where there is clinical evidence of tissue hypoxia) and type B (where there ...
  46. [46]
    An Overview of Type B Lactic Acidosis Due to Thiamine (B1 ...
    Type B lactic acidosis can occur secondary to several factors, including thiamine deficiency, and is not as common as type A.
  47. [47]
    (PDF) Lactic Acidosis In Critically Ill Patients - ResearchGate
    Key Words: Lactate, Pyruvate, Lactic acidosis,THAM. History: Lactic acidosis was first described in literature. in the year 1920. Clausen in the year 1925 ...
  48. [48]
    Lactate measurement: arterial versus venous blood sampling
    All studies reveal a bias, with venous blood lactate tending to be higher than arterial blood lactate. The magnitude of this bias, however, varies significantly ...
  49. [49]
    Correlation between arterial lactate and venous lactate in patients ...
    Mar 18, 2014 · The arterial lactate and venous lactate levels were strongly correlated in the condition of sepsis or septic shock.
  50. [50]
    Observational Analysis of Point-of-Care Lactate Plus™ Meter ... - MDPI
    The i-STAT® showed a small bias compared to the LA Plus™ meter (−0.0227 ± 0.4542 with 95% limits of agreement from −0.09129 to 0.8675). The LA Plus™ meter ...
  51. [51]
    Comparison of point‐of‐care and central laboratory analyzers for ...
    Mar 29, 2019 · The within-run tests on the i-STAT® analyzer demonstrated a coefficient of variation (CV) <5% for blood gas and lactate when control materials ...
  52. [52]
    Lactic Acid LAC - Laboratory Alliance of Central New York
    Method(s), Spectrophotometry. Synonym, Lactate. Specimen Required. Collect, One 6 mL gray (sodium fluoride & potassium oxalate) top tube. Transport.Missing: measurement | Show results with:measurement
  53. [53]
    Lactate Dehydrogenase - Assay - Worthington Biochemical
    The reaction velocity is determined by a decrease in absorbance at 340 nm resulting from the oxidation of NADH. One unit causes the oxidation of one micromole ...
  54. [54]
    Lactate measurement in whole blood using near infrared spectroscopy
    Aug 7, 2025 · Regression analysis provided a correlation coefficient of 0.984 and a standard error of 0.29 mmol/l between the enzymatic assay and the NIRS ...
  55. [55]
    Near-Infrared Spectroscopic Measurement of Lactate in Human ...
    A correlation coefficient of 0.995 and a standard error of 0.51 mmol/L were found between the enzymatic and the NIR results. This standard error is within the ...
  56. [56]
    Surviving sepsis campaign: international guidelines for ...
    Previous iterations of these guidelines have suggested using lactate levels as a target of resuscitation in the early phases of sepsis and septic shock, based ...
  57. [57]
    Lactated Ringer's Solution - an overview | ScienceDirect Topics
    Each liter contains 28 to 29 mmol of sodium lactate and is used for fluid resuscitation without significantly increasing serum lactate compared to normal saline ...
  58. [58]
    Ringer's Lactate - StatPearls - NCBI Bookshelf
    Jul 7, 2025 · Contraindications. Although not an absolute contraindication, caution is advised when administering Ringer lactate to patients with liver ...
  59. [59]
    Damage control resuscitation in patients with major trauma
    This review paper aims to provide insight in the latest developments of DCR focusing on the concept of hemostatic resuscitation of multiple trauma patients.
  60. [60]
    A Stand-Alone Synbiotic Treatment for the Prevention of D-Lactic ...
    We propose a stand-alone therapy using synbiotics for the prevention of D-lactic acidosis in patients with SBS.
  61. [61]
    Oxygen, pH, Lactate, and Metabolism—How Old Knowledge ... - NIH
    Thus, we can learn from all these studies that topical lactate application improves wound healing and reduces oxidative stress systemically. However, the ...
  62. [62]
    The Role of Lactic Acid in Episiotomy Wound Healing: A Systematic ...
    Lactic acid-treated wounds demonstrated 30% faster healing rates, 50% lower infection rates, and reduced pain scores compared with standard wound-care methods.
  63. [63]
    Lactated ringer's (intravenous route) - Side effects & uses - Mayo Clinic
    Feb 1, 2025 · Liver disease, severe—Use with caution. This medicine may not increase the pH level in this condition due to a decrease in the metabolism of ...
  64. [64]
    History and Biochemistry of Fermented Foods - RockEDU
    As such, lactic acid fermentation has been used by countless cultures for centuries for food preservation. More recently, LAB bacteria have been shown to be ...Missing: pickling strains
  65. [65]
    (PDF) Biotechnological production of lactic acid and its recent ...
    Aug 9, 2025 · We present a review of lactic acid-producing microorganisms, raw materials for lactic acid production, fermentation approaches for lactic acid production, and ...
  66. [66]
    Lactic Acid Fermentations - NCBI
    Lactic acid fermentations are used in foods like sauerkraut, yogurt, and salami, and are low cost, fuel efficient, and preserve food.Missing: via | Show results with:via
  67. [67]
    Yogurt - The Nutrition Source - Harvard University
    Yogurt is made by fermenting heated milk with bacteria, and it contains protein, calcium, and live bacteria. It may help with weight gain and diabetes.Yogurt And Health · Purchase · MakeMissing: via | Show results with:via
  68. [68]
    sodium lactate - cfsanappsexternal.fda.gov
    No. is the FEMA GRAS™ publication number. NLFG is no longer FEMA GRAS™. For more information about FEMA GRAS, see About the FEMA GRAS™ Program <External Link ...
  69. [69]
    calcium lactate - cfsanappsexternal.fda.gov
    Food additive and GRAS regulations (21 CFR Parts 170-186)*:, 184.1207. Food labeling and standards regulations (21 CFR Parts 100-169):, 145.145. Select ...
  70. [70]
    Natural Antimicrobials for Listeria monocytogenes in Ready-to-Eat ...
    May 16, 2023 · Sodium lactate inhibits the growth of bacteria by reducing the water activity of food products, delaying the development of bacteria, and ...<|separator|>
  71. [71]
    [PDF] Survival and Growth of Listeria monocytogenes in Broth as a ...
    The objective of this study was to determine the antimicrobial effect of a combination of potassium lactate and sodium diacetate (0, 1.8, 3, ...
  72. [72]
    Role of Lactic Acid Bacteria in Food Preservation and Safety - PMC
    Certain strains of LAB demonstrated antimicrobial activity against foodborne pathogens, including bacteria, yeast and filamentous fungi.
  73. [73]
    LACTIC ACID USP/PH.EUR/BP PARENTEX | Innovative Formulations
    Excipient developed for pharmaceutical preparations. It is used as a buffering agent and pH modifier in injectable formulations.
  74. [74]
    [PDF] Excipients and Their Role in Approved Injectable Products
    Cipro IV威 (ciprofloxacin, Bayer) contains lactic acid as a solubilizing agent for the antibiotic. 3. Premarin Injection威 (conjugated estrogens,. Wyeth ...
  75. [75]
    A Guide to Different Types of Acids in the Pharmaceutical Industry
    Sep 15, 2023 · Lactic acid is a naturally occurring organic acid found in various foods and is used in the pharmaceutical industry as a pH adjuster and ...
  76. [76]
    Polylactic acid (PLA) controlled delivery carriers for biomedical ...
    These polymers have been approved by US Food and Drug Administration (FDA) for human use as sutures, bone implants, and screws, and in formulations for ...
  77. [77]
    Promising Role of Polylactic Acid as an Ingenious Biomaterial in ...
    Jan 4, 2023 · Food and Drug Administration Approved PLA Formulations Used in Medicine. The use of PLA in various medical surgeries, implants, and drug ...
  78. [78]
    Review Medical applications and prospects of polylactic acid materials
    Dec 20, 2024 · For instance, PLA and PLGA have been approved by FDA for human use in formulations for controlled release drug delivery and as carriers for ...
  79. [79]
  80. [80]
    Evaluation of a moisturizer containing sodium lactate and urea to ...
    Conclusion: A commercially available moisturizing cream containing 10% urea and 5% sodium lactate is safe and effective in ameliorating the symptoms of xerotic ...<|separator|>
  81. [81]
    Moisturizer in Patients with Inflammatory Skin Diseases - PMC - NIH
    Lactic acid is an AHA and a component of a natural moisturizing factor. It induces the formation of ceramides in keratinocytes as well as the exfoliation of ...
  82. [82]
    Enabling tumor-specific drug delivery by targeting the Warburg effect ...
    Jan 21, 2025 · In this study, we developed a lactate-responsive drug carrier based on enzyme-assisted Janus mesoporous silica nanoparticles. In this ...
  83. [83]
  84. [84]
    Isolation and characterization of bacteria capable of degrading poly ...
    Four bacteria, Chryseobacterium sp., Sphingobacterium sp. and two strains of Pseudomonas aeruginosa, capable of degrading poly(lactic acid), PLA, at ...
  85. [85]
    The Pseudomonas aeruginosa Complement of Lactate ... - NIH
    Sep 11, 2018 · P. aeruginosa produces four enzymes annotated as lactate dehydrogenases, three of which are known to contribute to anaerobic or aerobic metabolism in liquid ...Missing: biodegradation | Show results with:biodegradation
  86. [86]
    A Comparative Review on Biodegradation of Poly(Lactic Acid) in ...
    The present review offers a comprehensive analysis of the biodegradation behavior of PLA in diverse environmental settings, with a specific focus on soil, ...
  87. [87]
    Effect of Lactate and Starter Inoculum on Biogas Production from ...
    Discover the impact of lactic acid on biogas production. Our study reveals a 45% increase in biogas yield with lactate-rich maize silage.
  88. [88]
    Evaluation of the potential of utilizing lactic acid bacteria and dairy ...
    Mar 14, 2017 · The pre-treatment of dairy WWs with anaerobic sludge for 11 days effectively decreases the COD and BOD of 99.9% and 99.4%, respectively. The ...
  89. [89]
    Evaluation of Anaerobic Digestion of Dairy Wastewater in an ... - MDPI
    The highest biogas yield of 0.33 ± 0.03 L/g COD removed and methane content in biogas of 68.1 ± 5.8% were recorded at OLR of 1.0 g COD/L·d, while at OLR of 2.0 ...Missing: lactate | Show results with:lactate
  90. [90]
    Coastal ocean acidification: The other eutrophication problem
    Jul 5, 2014 · Eutrophication enhanced microbial respiration was the prime source of acidification. •. Acidification reached levels shown to negatively affect ...<|separator|>
  91. [91]
    Coastal eutrophication drives acidification, oxygen loss, and ... - PNAS
    Global change is leading to warming, acidification, and oxygen loss in the ocean. In the Southern California Bight, an eastern boundary upwelling system, ...Missing: bacterial | Show results with:bacterial
  92. [92]
    Impacts of poly(lactic acid) microplastics on organic compound ...
    Nov 25, 2023 · Studies have demonstrated that the degradation of PLA-MPs can lead to the release of lactic acid and other degradation byproducts (Mu et al., ...<|control11|><|separator|>
  93. [93]
    The Analysis of Polylactic Acid Oligomers and Their Fate in ...
    Apr 30, 2025 · This study suggests that PLA oligomers from PLA-based degradable products are often overlooked in soil environments.
  94. [94]
    Plastics of the Future? An Interdisciplinary Review on Biobased and ...
    Mar 24, 2025 · For instance, the breakdown of PLA releases lactic acid, which can alter soil pH and affect microbial communities. Moreover, even if ...